Wheeler Bio

About:

Wheeler Bio is a biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact.

Website: https://www.wheelerbio.com/

Top Investors: Alloy Therapeutics, Charles River Laboratories International, ATUM, Presbyterian Health Foundation, Echo Investment Capital

Description:

Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, biomanufacturing and portable CMC platform. Wheeler Bio was established in 2020 by Jesse McCool in Oklahoma City.

Total Funding Amount:

$45M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Oklahoma City, Oklahoma, United States

Founded Date:

2020-01-01

Founders:

Jesse McCool

Number of Employees:

51-100

Last Funding Date:

2022-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai